Human Health and Potential (HHP)

Contrary to popular belief, a new A*STAR study shows that HIV mutations are far from random, emerging at specific locations at specific rates.

Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening yeast infections to flourish.

Elevated levels of inflammatory factors may be linked to persistent COVID-19 symptoms, researchers find.

A protein in cilia called CFAP53 is responsible for the distinct beat patterns during embryonic development, researchers say.

Induced pluripotent stem cells have helped researchers map the role of the RFX6 gene in a rare congenital disorder known as Mitchell-Riley Syndrome.

A*STAR researchers have created the first machine learning model for predicting clinical outcomes of stem cell therapies in patients with cartilage disorders.

A newly-discovered role for an immune regulator in T cells may help unravel the molecular basis of inflammatory bowel disease and serve as a promising therapeutic target.

Asian patients with suspected but undiagnosed rare genetic diseases could get answers sooner thanks to next-generation sequencing technologies.

A newly-designed antimicrobial polymer offers a 2-in-1 solution to combat multidrug-resistant bacteria.

Data shows that antibodies produced as part of the COVID-19 immune response can neutralize a more transmissible variant of SARS-CoV-2.

Tracking how SARS-CoV-2 interacts with host cell receptors during infections may give us new ideas for COVID-19 drug targets.

Scientists identify a key molecular marker of muscle stem cells, providing novel insights into the mechanisms around muscle regeneration.